PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New technique identifies novel class of cancer's drivers

Sieving through 'junk' DNA reveals disease-causing genetic mutations

2013-10-04
(Press-News.org) Researchers can now identify DNA regions within non-coding DNA, the major part of the genome that is not translated into a protein, where mutations can cause diseases such as cancer.

Their approach reveals many potential genetic variants within non-coding DNA that drive the development of a variety of different cancers. This approach has great potential to find other disease-causing variants.

Unlike the coding region of the genome where our 23,000 protein-coding genes lie, the non-coding region - which makes up 98% of our genome – is poorly understood. Recent studies have emphasised the biological value of the non-coding regions, previously considered 'junk' DNA, in the regulation of proteins. This new information provides a starting point for researchers to sieve through the non-coding regions and identify the most functionally important regions.

"Our technique allows scientists to focus in on the most functionally important parts of the non-coding regions of the genome," says Professor Mark Gerstein, senior author from the University of Yale. "This is not just beneficial for cancer research, but can be extended to other genetic diseases too."

The team used the full set of genetic variants from the first phase of the 1000 Genomes Project, together with information about the non-coding regions generated by the ENCODE Project, and identified regions that did not accumulate much variation. Protein-coding genes play a crucial role in human survival and fitness, and are under strong 'purifying' selection, which removes variation. The team found that some non-coding DNA regions showed almost the same low levels of variation as protein-coding genes, and called these 'ultrasensitive' regions.

Within the ultrasensitive regions, they looked at specific single DNA letters that, when altered, caused the greatest disturbance to the genetic region. If this non-coding, ultrasensitive region is central to a network of many related genes, variation can cause a greater knock-on effect, resulting in disease.

They integrated all this information to develop a computer workflow known as FunSeq. This system prioritises genetic variants in the non-coding regions based on their predicted impact on human disease. "Our method is a practical and successful way to screen for purifying selection in non-coding regions of the genome using freely available data such as those from the ENCODE and 1000 Genomes Projects," says Dr Yali Xue, author from the Wellcome Trust Sanger Institute. "It really shows the value of these large-scale open access data-sets."

The team applied FunSeq to 90 cancer genomes including breast cancer, prostate cancer and brain tumours, and found nearly 100 potential non-coding cancer driving variants. In the breast cancer genomes, for example, they found a single DNA letter change that seems to have great impact on the development of breast cancer. This single letter change occurs in an ultrasensitive region that is central to a network of many related genes.

"Although we see that the first effective use of our tool is for cancer genomes, this method can be applied to find any potential disease-causing variant in the non-coding regions of the genome," says Dr Chris Tyler-Smith, lead author from the Wellcome Trust Sanger Institute. "We are excited about the vast potential of this method to find further disease-causing, and also beneficial variants, in these crucial but unexplored areas of our genome."

### Notes to Editors The 1000 Genomes Project is the first project to sequence the genomes of a large number of people, to provide a comprehensive resource on human genetic variation.
http://www.1000genomes.org/

ENCODE, the Encyclopedia of DNA Elements, is a project funded by the National Human Genome Research Institute to identify all regions of transcription, transcription factor association, chromatin structure and histone modification in the human genome sequence.
http://www.genome.gov/10005107

The aim of GENCODE as a sub-project of the ENCODE scale-up project is to annotate all evidence-based gene features in the entire human genome at a high accuracy. The result will be a set of annotations including all protein-coding loci with alternatively transcribed variants, non-coding loci with transcript evidence, and pseudogenes.
http://www.gencodegenes.org/

Publication Details Ekta Khurana, Yao Fu, Vincenza Colonna, Xinmeng Jasmine Mu et al (2013). "Integrative annotation of variants from 1,092 humans: application to cancer genomics" Advanced online publication in Science, 03 October, 2013

Funding A full list of funding can be found on the paper

Participating Centres A full list of participating centres can be found on the paper

Selected Websites The Wellcome Trust Sanger Institute is one of the world's leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease. http://www.sanger.ac.uk

The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests. http://www.wellcome.ac.uk

Contact details Don Powell Media Manager
Wellcome Trust Sanger Institute
Hinxton, Cambridge, CB10 1SA, UK
Tel +44 (0)1223 496 928
Mobile +44 (0)7753 7753 97
Email press.office@sanger.ac.uk


ELSE PRESS RELEASES FROM THIS DATE:

Silencing sudden death

2013-10-04
Hypertrophic cardiomyopathy (HCM), a disease in which cardiac muscle thickens, weakening the heart, can be prevented from developing for several months in mice by reducing production of a mutant protein, according to a new study by researchers at Harvard Medical School. The work takes a first step toward being able to treat or prevent the leading cause of sudden death in athletes and sudden heart-related death inpeople under 30 in the United States. "There's really no treatment for HCM right now. You can treat symptoms like chest pain or an arrhythmia, but that's not ...

Chemistry with sorted molecules

2013-10-04
To gain complete control over chemical reactions is one of the main goals of chemists around the world. Scientists at the University of Basel and the Center of Free-Electron Laser Science in Hamburg were able to for the first time successfully sort out single forms of molecules with electric fields and have them react specifically. Analysis of the reaction rates showed a relation between the spatial structure of the sorted molecules and their chemical reactivity. The results have been published in the renowned magazine Science. The reactivity of a chemical compound, ...

Stowers team links dampened mTOR signaling with the developmental disorder Roberts syndrome

2013-10-04
VIDEO: Watch as Stowers Investigator Jennifer Gerton, Ph.D. describes her most recent research discovery. Click here for more information. KANSAS CITY, MO—Children born with developmental disorders called cohesinopathies can suffer severe consequences, including intellectual disabilities, limb shortening, craniofacial anomalies, and slowed growth. Researchers know which mutations underlie some cohesinopathies, but have developed little understanding of the downstream signals ...

Possible culprits in congenital heart defects identified

2013-10-04
Mitochondria are the power plants of cells, manufacturing chemical fuel so a cell can perform its many tasks. These cellular power plants also are well known for their role in ridding the body of old or damaged cells. Now, researchers at Washington University School of Medicine in St. Louis and the University of Padua-Dulbecco Telethon Institute in Italy have shown that mitochondria remarkably also orchestrate events that determine a cell's future, at least in the embryonic mouse heart. The new study identifies new potential genetic culprits in the origins of some congenital ...

Brain stimulation affects compliance with social norms

2013-10-04
How does the human brain control compliance with social norms? The biological mechanisms that underlie norm compliance are still poorly understood. In a new study, Christian Ruff, Giuseppe Ugazio, and Ernst Fehr from the University of Zurich show that the lateral prefrontal cortex plays a central role in norm compliance. Prefrontal cortex controls norm behavior For the study, 63 participants took part in an experiment in which they received money and were asked to decide how much of it they wanted to share with an anonymous partner. A prevalent fairness norm in Western ...

Genetic study of river herring populations identifies conservation priorities

2013-10-04
A genetic and demographic analysis of river herring populations along the U.S. east coast, published October 2 in Evolutionary Applications, has identified distinct genetic stocks, providing crucial guidance for efforts to manage their declining populations. River herring include two related species, alewife and blueback herring, which migrate between freshwater spawning grounds and the ocean, where they spend most of their lives. The species are important for both ecological and economic reasons, according to Eric Palkovacs, assistant professor of ecology and evolutionary ...

3-D printing: The greener choice

2013-10-04
3D printing isn't just cheaper, it's also greener, says Michigan Technological University's Joshua Pearce. Even Pearce, an aficionado of the make-it-yourself-and-save technology, was surprised at his study's results. It showed that making stuff on a 3D printer uses less energy—and therefore releases less carbon dioxide—than producing it en masse in a factory and shipping it to a warehouse. Most 3D printers for home use, like the RepRap used in this study, are about the size of microwave ovens. They work by melting filament, usually plastic, and depositing it layer by ...

How Instagram can ruin your dinner

2013-10-04
Warning Instagrammers: you might want to stop taking so many pictures of your food. New research out of Brigham Young University finds that looking at too many pictures of food can actually make it less enjoyable to eat. Turns out your foodie friend's obsession with taking pictures of everything they eat and posting it on Instagram or Pinterest may be ruining your appetite by making you feel like you've already experienced eating that food. "In a way, you're becoming tired of that taste without even eating the food," said study coauthor and BYU professor Ryan Elder. ...

Genetics used to sort out poorly known -- and hunted -- whale species

2013-10-04
Saving the whales often means knowing—sometimes genetically—one group of whales from another, say researchers attempting to define populations of a medium-sized and poorly understood baleen whale that is sometimes targeted by Japan's scientific whaling program. In a new study, scientists from Wildlife Conservation Society, the American Museum of Natural History, Columbia University, NOAA, and other groups are working to define separate groups and subspecies of the Bryde's whale in the Indian and western Pacific Oceans. By generating genetic information that allowed ...

New data-driven machine learning method effectively flags risk for post-stroke dangers

2013-10-04
PHILADELPHIA - A team of experts in neurocritical care, engineering, and informatics, with the Perelman School of Medicine at the University of Pennsylvania, have devised a new way to detect which stroke patients may be at risk of a serious adverse event following a ruptured brain aneurysm. This new, data-driven machine learning model, involves an algorithm for computers to combine results from various uninvasive tests to predict a secondary event. Preliminary results were released at the Neurocritical Care Society Annual Meeting in Philadelphia. Comparing 89 patient ...

LAST 30 PRESS RELEASES:

Modulation of antiviral response in fungi via RNA editing

Global, regional, and national burden of nontraumatic subarachnoid hemorrhage

Earliest use of psychoactive and medicinal plant ‘harmal’ identified in Iron Age Arabia

Nano-scale biosensor lets scientists monitor molecules in real time

Study shows how El Niño and La Niña climate swings threaten mangroves worldwide

Quantum eyes on energy loss: diamond quantum imaging for next-gen power electronics

Kyoto conundrum: More hotels than households exist in ancient capital

Cluster-root secretions improve phosphorus availability in low-phosphorus soil

Hey vespids, what's for dinner? DNA analysis of wasp larvae’s diverse diet

Street smarts: how a hawk learned to use traffic signals to hunt more successfully

Muscle quality may hold clues to early cognitive decline

Autophagy and lysosomal pathways orchestrate unconventional secretion of Parkinson’s disease protein

Mystery of “very odd” elasmosaur finally solved: one of North America’s most famous fossils identified as new species

Half the remaining habitat of Australia's most at-risk species is unprotected

Study reveals influence behind illegal bear bile consumption in Việt Nam

Satellites offer new view of Chesapeake Bay’s marine heat waves

Experimental drug may benefit some patients with rare form of ALS

Early testing could make risky falls a thing of the past for elderly people

A rule-breaking, colorful silicone that could conduct electricity

Even weak tropical cyclones raise infant mortality in poorer countries, USC-led research finds

New ketamine study promises extended relief for depression

Illinois physicists develop revolutionary measurement tool, exploiting quantum properties of light

Moffitt to present plenary and late-breaking data on blood, melanoma and brain metastases at ASCO 2025

Future risk of wildfire and smoke in the South

On-site health clinics boost attendance in rural classrooms

Ritu Banga Healthcare Disparities Research Awards support innovative science

New tools to treat retinal degenerations at advanced stages of disease

Brain drain? More like brain gain: How high-skilled emigration boosts global prosperity

City of Hope researchers to present cancer advances that could boost survival at the American Society of Clinical Oncology (ASCO) Annual Meeting

A new approach could fractionate crude oil using much less energy

[Press-News.org] New technique identifies novel class of cancer's drivers
Sieving through 'junk' DNA reveals disease-causing genetic mutations